Form D · Other
Clara Labs, Inc.
San Francisco, CA · CIK 0001713147
Offering snapshot reported Sep 22, 2017 · SEC filing
- Reported sold
- $11.6M Offering amount: $11.7M
- Investors reported
- 28 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 3, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 22, 2017 | Initial | $11,634,199 | No comparison | 28 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-295180
Amount sold included certain discounts resulting from the conversion of convertible debt.
Source: Form D, filed Sep 22, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Akilian | Director, Executive |
| Xuezhao Lan | Director |
| Maran Nelson | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
576 Sacramento Street, 5 Th Floor
San Francisco, CA, 94111
San Francisco, CA, 94111